| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ACTBIO.2011.03.023 |
| P8608 | Fatcat ID | release_7zrcqvtbonae7dmusu6srhbflm |
| P932 | PMC publication ID | 3710784 |
| P698 | PubMed publication ID | 21439412 |
| P5875 | ResearchGate publication ID | 50865906 |
| P50 | author | Amanda E Ramer-Tait | Q42426185 |
| Jennifer Wilson-Welder | Q58338884 | ||
| P2093 | author name string | Balaji Narasimhan | |
| Michael J Wannemuehler | |||
| Bryan H Bellaire | |||
| Yashdeep Phanse | |||
| Brenda Carrillo-Conde | |||
| Senja K Lopac | |||
| Maria P Torres | |||
| P2860 | cites work | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 |
| T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
| Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses | Q58867360 | ||
| Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity | Q62132710 | ||
| Controlled delivery systems for proteins using polyanhydride microspheres | Q70684838 | ||
| In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks | Q71488945 | ||
| In vivo degradation and biocompatibility of a new class of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids | Q77844761 | ||
| Histocompatibility of photocrosslinked polyanhydrides: a novel in situ forming orthopaedic biomaterial | Q78667282 | ||
| Vaccine development: baring the 'dirty little secret' | Q80368692 | ||
| Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres | Q30379368 | ||
| High-throughput analysis of protein stability in polyanhydride nanoparticles | Q30388025 | ||
| New polymeric carriers for controlled drug delivery following inhalation or injection | Q30721607 | ||
| Microphase separation in bioerodible copolymers for drug delivery | Q31988872 | ||
| Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery | Q32050099 | ||
| Polymer chemistry influences monocytic uptake of polyanhydride nanospheres | Q33383038 | ||
| High throughput cell-based screening of biodegradable polyanhydride libraries | Q33468606 | ||
| Single-administration vaccines: controlled-release technology to mimic repeated immunizations | Q33546823 | ||
| Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes | Q33788047 | ||
| DC-SIGN: a guide to some mysteries of dendritic cells. | Q33866265 | ||
| New advances in microsphere-based single-dose vaccines | Q33933148 | ||
| Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines | Q33933255 | ||
| CD40 and dendritic cell function | Q34220591 | ||
| Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. | Q34324135 | ||
| Toxicity, biodegradation and elimination of polyanhydrides | Q34971406 | ||
| The development of polyanhydrides for drug delivery applications | Q35256482 | ||
| Controlled release of polypeptides from polyanhydrides | Q36285043 | ||
| Immunomodulatory biomaterials | Q37228960 | ||
| TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. | Q37235039 | ||
| Vaccine adjuvants: current challenges and future approaches. | Q37244036 | ||
| Amphiphilic polyanhydrides for protein stabilization and release | Q40289460 | ||
| Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells | Q40290476 | ||
| Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation | Q42117985 | ||
| Antigen delivery systems and immunostimulation | Q43885814 | ||
| Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides | Q44054861 | ||
| Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery | Q44130331 | ||
| Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. | Q45112818 | ||
| Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells | Q45413835 | ||
| The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells. | Q45962091 | ||
| Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms | Q46683398 | ||
| Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism | Q46848409 | ||
| Protein stability in the presence of polymer degradation products: consequences for controlled release formulations | Q46965558 | ||
| Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage | Q47179682 | ||
| The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres. | Q51036883 | ||
| Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. | Q51615861 | ||
| Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. | Q54050413 | ||
| Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements | Q57228054 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 7 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 2857-2864 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Polyanhydride microparticles enhance dendritic cell antigen presentation and activation | |
| P478 | volume | 7 |
| Q41879397 | A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms |
| Q35887551 | Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. |
| Q64951879 | Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. |
| Q91780875 | An overview of biodegradable nanomaterials and applications in vaccines |
| Q36591050 | Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases |
| Q38212549 | Applying biodegradable particles to enhance cancer vaccine efficacy |
| Q41382718 | Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage |
| Q89712313 | Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines |
| Q36502434 | Biodegradable particles as vaccine delivery systems: size matters |
| Q91909130 | Biodegradable polymers for modern vaccine development |
| Q90601136 | Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms |
| Q42114702 | Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells |
| Q36582010 | Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles |
| Q51567300 | Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant. |
| Q36957938 | Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery |
| Q64106279 | Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of infection |
| Q92421550 | Effect of the Hydrophilic-Hydrophobic Balance of Antigen-Loaded Peptide Nanofibers on Their Cellular Uptake, Cellular Toxicity, and Immune Stimulatory Properties |
| Q50317606 | Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf |
| Q47248817 | Emerging trends in the immunotherapy of pancreatic cancer. |
| Q46989472 | Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery |
| Q47201342 | Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination. |
| Q38757220 | Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants. |
| Q42426154 | Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles |
| Q36317368 | High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles |
| Q36690859 | Materials that harness and modulate the immune system |
| Q38257645 | Nanoparticle based-immunotherapy against allergy. |
| Q33834985 | Nanoparticle-allergen complexes for allergen immunotherapy. |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q26997993 | Particle-mediated delivery of cytokines for immunotherapy |
| Q51534139 | Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses. |
| Q57167166 | Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections |
| Q33710195 | Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses |
| Q39002525 | Polyanhydride nanovaccine against swine influenza virus in pigs |
| Q35619618 | Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. |
| Q38038244 | Recent advances in polymeric microspheres for parenteral drug delivery--part 2. |
| Q36598433 | Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation |
| Q51732398 | Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity. |
| Q34871862 | Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles |
| Q37611358 | Self-assembled PEG-b-PDPA-b-PGEM copolymer nanoparticles as protein antigen delivery vehicles to dendritic cells: preparation, characterization and cellular uptake |
| Q92326288 | Sensitive detection of antigen-specific T-cells using bead-bound antigen for in vitro re-stimulation |
| Q50928936 | Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. |
| Q90696345 | Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague |
| Q38982074 | Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation |
| Q38162446 | Targeting antigens to dendritic cell receptors for vaccine development |
| Q38722460 | The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response |
| Q42926219 | The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation |
Search more.